Show Parent

March

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review Roeland Vis, Ewoudt M.W. van de Garde, Jan C. Grutters, Ingrid H.E. Korenromp Eur Respir Rev, 29 (155) 190057; 10.1183/16000617.0057-2019
Is bronchiectasis really a disease? Michal Shteinberg, Patrick A. Flume, James D. Chalmers Eur Respir Rev, 29 (155) 190051; 10.1183/16000617.0051-2019
European Respiratory Review, list of peer reviewers 2019 Eur Respir Rev, 29 (155) 515120; 10.1183/16000617.5151-2020
Natural enemy or friend? Pneumonia in the very elderly critically ill patient Michael S. Niederman Eur Respir Rev, 29 (155) 200031; 10.1183/16000617.0031-2020
Modulator treatment for people with cystic fibrosis: moving in the right direction J. Stuart Elborn Eur Respir Rev, 29 (155) 200051; 10.1183/16000617.0051-2020
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages Nicolas Guibert, Anne Pradines, Gilles Favre, Julien Mazieres Eur Respir Rev, 29 (155) 190052; 10.1183/16000617.0052-2019
a₁-Antitrypsin deficiency and chronic respiratory disorders Mario Cazzola, Daiana Stolz, Paola Rogliani, Maria Gabriella Matera Eur Respir Rev, 29 (155) 190073; 10.1183/16000617.0073-2019
Schistosomiasis-associated pulmonary arterial hypertension: a systematic review Daniela Knafl, Christian Gerges, Charles H. King, Marc Humbert, Amaya L. Bustinduy Eur Respir Rev, 29 (155) 190089; 10.1183/16000617.0089-2019
Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis Diana P. Pozuelo-Carrascosa, Ángel Herráiz-Adillo, Celia Alvarez-Bueno, Jose Manuel Añón, Vicente Martínez-Vizcaíno, Iván Cavero-Redondo Eur Respir Rev, 29 (155) 190107; 10.1183/16000617.0107-2019
Community-acquired pneumonia in critically ill very old patients: a growing problem Catia Cillóniz, Cristina Dominedò, Juan M. Pericàs, Diana Rodriguez-Hurtado, Antoni Torres Eur Respir Rev, 29 (155) 190126; 10.1183/16000617.0126-2019
Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target Michael J. Hughes, Helen M. McGettrick, Elizabeth Sapey Eur Respir Rev, 29 (155) 190102; 10.1183/16000617.0102-2019
How can we minimise the use of regular oral corticosteroids in asthma? Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devilliers, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val, Pascal Chanez Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Michal Shteinberg, Jennifer L. Taylor-Cousar Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019
Clinical phenotyping: role in treatment decisions in sarcoidosis Robert P. Baughman, Mary Beth Scholand, Franck F. Rahaghi Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis Franck F. Rahaghi, Robert P. Baughman, Lesley Ann Saketkoo, Nadera J. Sweiss, Joseph B. Barney, Surinder S. Birring, Ulrich Costabel, Elliott D. Crouser, Marjolein Drent, Alicia K. Gerke, Jan C. Grutters, Nabeel Y. Hamzeh, Isham Huizar, W. Ennis James, Sanjay Kalra, Susanna Kullberg, Huiping Li, Elyse E. Lower, Lisa A. Maier, Mehdi Mirsaeidi, Joachim Müller-Quernheim, Eva M. Carmona Porquera, Lobelia Samavati, Dominique Valeyre, Mary Beth Scholand Eur Respir Rev, 29 (155) 190146; 10.1183/16000617.0146-2019
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study Franck F. Rahaghi, Nadera J. Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph B. Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, Lanier O'Hare, Mark J. Rumbak, Lobelia Samavati, Robert P. Baughman Eur Respir Rev, 29 (155) 190147; 10.1183/16000617.0147-2019
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051. Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019
“How can we minimise the use of regular oral corticosteroids in asthma?” Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devillier, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val and Pascal Chanez. Eur Respir Rev 2020; 29: 190085. Eur Respir Rev, 29 (155) 195085; 10.1183/16000617.5085-2019
Protecting healthcare workers from SARS-CoV-2 infection: practical indications Martina Ferioli, Cecilia Cisternino, Valentina Leo, Lara Pisani, Paolo Palange, Stefano Nava Eur Respir Rev, 29 (155) 200068; 10.1183/16000617.0068-2020
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety David Price, Mario Castro, Arnaud Bourdin, Sebastian Fucile, Pablo Altman Eur Respir Rev, 29 (155) 190151; 10.1183/16000617.0151-2019